---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-256710"
form_type: "8-K"
ticker: "TYRA"
cik: "0001863127"
company_name: "Tyra Biosciences, Inc."
filed_at: "2022-10-03T23:59:59+00:00"
generated_at: "2026-06-23T06:07:20.639039+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tyra Biosciences enters $150M ATM equity offering facility with Virtu Americas

## Summary
- Company may sell up to $150M of common stock at prevailing market prices through Agent Virtu Americas LLC.
- Agent receives commission up to 3.0% of gross proceeds; no obligation for Company to sell any shares.
- Shares issued under shelf registration statement filed with SEC on October 3, 2022.
- Either party may terminate the Sales Agreement at any time on prior written notice.

## SEC filing metadata
- accession: 0001193125-22-256710
- form_type: 8-K
- ticker: TYRA
- cik: 0001863127
- company_name: Tyra Biosciences, Inc.
- filed_at: 2022-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1863127/000119312522256710/0001193125-22-256710-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1863127/000119312522256710/d378227d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-256710
- JSON: https://secwatch.observer/filing/0001193125-22-256710.json
- Plain text: https://secwatch.observer/filing/0001193125-22-256710.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.